VARITECT CP sol perf 125 UI/5ml vial 5 ml
7680594510012
CH-59451
J06BB03
08.09.
Reimbursement limitations:
EXPO SCHWANG
Exposition durant la grossesse et chez les patients atteints d'une déficience immunitaire.
1 / 3
google
Details
- Product number
- 5945101
- CPT
- -
- Packaging group
- 125
- Unit
- I.E.
- Composition
- immunoglobulinum humanum varicellae 25 U.I. corresp. proteina plasmatis humani 50 mg ex illo immunoglobulinum humanum normale (IgG1: ca. 62 %, IgG2: ca. 33 %, IgG3: ca. 3 %, IgG4: ca. 2 %) 96 %, immunoglobulinum humanum A max. 2 mg, glycinum, aqua q.s. ad solutionem pro 1 ml.
Articles (1)
Varitect CP, Lösung zur intravenösen Injektion
Lösung zur intravenösen Injektion
125
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
25.0 UI | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
50.0 MG | Substance | WIZUS |
|
(N/A)
|
96.0 P | Substance | WIZUS |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 165.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2009
Authorization holder
Biotest (Schweiz) AG
5102 Rupperswil
Authorization information
- Swissmedic authorization number
- 59451
- Drug name
- Varitect CP, Lösung zur intravenösen Injektion
- Galenic form
- LSPA
- ATC Code
- J06BB03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 13/01/2009
- Authorization expiration date
- 31/12/9999
- IT number
- 08.09.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VARITECT CP sol perf 125 UI/5ml vial 5 ml
- Description (DE)
- VARITECT CP Inf Lös 125 IE/5ml Vial 5 ml
- Market launch
- 13/01/2009
- Narcotic (BTM)
- No
Application methods
IV